NERM
ELV icon

New England Research & Management’s Elevance Health ELV Stock Holding History

New England Research & Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,650
Closed -$858K – 157
2024
Q3 		$858K Sell
1,650
-50
-3% -$26.7K 0.4% 79
2024
Q2 		$921K Sell
1,700
-325
-16% -$172K 0.44% 75
2024
Q1 		$1.05M Buy
2,025
+125
+7% +$62.2K 0.52% 65
2023
Q4 		$896K Sell
1,900
-35
-2% -$16.2K 0.47% 77
2023
Q3 		$843K Sell
1,935
-1,190
-38% -$540K 0.48% 73
2023
Q2 		$1.39M Sell
3,125
-365
-10% -$168K 0.81% 47
2023
Q1 		$1.6M Sell
3,490
-710
-17% -$338K 0.94% 31
2022
Q4 		$2.15M Sell
4,200
-1,240
-23% -$630K 1.24% 22
2022
Q3 		$2.47M Buy
5,440
+925
+20% +$443K 1.56% 17
2022
Q2 		$2.18M Buy
4,515
+1,275
+39% +$631K 1.27% 23
2022
Q1 		$1.59M Hold
3,240
– – 0.83% 42
2021
Q4 		$1.5M Hold
3,240
– – 0.73% 45
2021
Q3 		$1.21M Hold
3,240
– – 0.63% 54
2021
Q2 		$1.24M Sell
3,240
-1,200
-27% -$459K 0.64% 56
2021
Q1 		$1.59M Buy
+4,440
New +$1.43M 0.87% 39
2016
Q3 		– Sell
-5,450
Closed -$716K – 170
2016
Q2 		$716K Sell
5,450
-50
-0.9% -$6.84K 0.62% 49
2016
Q1 		$764K Hold
5,500
– – 0.65% 52
2015
Q4 		$767K Buy
5,500
+2,700
+96% +$372K 0.66% 53
2015
Q3 		$392K Buy
+2,800
New +$421K 0.37% 98

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

New England Research & Management's ELV Position: Q4 2024 in Review

New England Research & Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 1,650 shares — an estimated $858K sold.

New England Research & Management first reported a position in ELV in Q3 2015 and held it in 19 quarters. The position peaked at $2.47M in Q3 2022. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • New England Research & Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • New England Research & Management sold 1,650 Elevance Health shares in Q4 2024, an estimated $858K.
  • New England Research & Management first reported a position in Elevance Health in Q3 2015 and held it in 19 quarters.
  • New England Research & Management's Elevance Health position peaked at $2.47M in Q3 2022.
  • 1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on New England Research & Management's 13F filing for Q4 2024, filed 23 Jan 2025.